{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T08:52:07Z","timestamp":1791881527307,"version":"4.3.4"},"reference-count":117,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100022809","name":"First Teaching Hospital of Tianjin University of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["JYTC2025015"],"award-info":[{"award-number":["JYTC2025015"]}],"id":[{"id":"10.13039\/100022809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ibroneuroscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.neuroscience.2026.09.016","type":"journal-article","created":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T06:44:27Z","timestamp":1789195467000},"page":"1-18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Targeting oxaliplatin-induced peripheral neuropathy: neurobiological mechanisms, therapeutic evidence, and translational perspectives"],"prefix":"10.1016","volume":"616","author":[{"given":"Tian","family":"Yuanyuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhou","family":"Juyue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xie","family":"Yingying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Lefan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Guixin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cui","family":"Jiaming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Jianchun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wentao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.neuroscience.2026.09.016_b0005","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1007\/s00204-024-03742-1","article-title":"Interaction of the chemotherapeutic agent oxaliplatin and the tyrosine kinase inhibitor dasatinib with the organic cation transporter 2","volume":"98","author":"Ahmed Eltayeb","year":"2024","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.neuroscience.2026.09.016_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107905","article-title":"Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity","volume":"164","author":"Alberti","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2026.09.016_b0015","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.2147\/DDDT.S385914","article-title":"The combination of zinc and melatonin enhanced neuroprotection and attenuated neuropathy in oxaliplatin-induced neurotoxicity","volume":"16","author":"Ali","year":"2022","journal-title":"Drug Des. Devel. Ther."},{"issue":"5","key":"10.1016\/j.neuroscience.2026.09.016_b0020","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3892\/etm.2012.678","article-title":"Effects of calcium and magnesium on acute and chronic neurotoxicity caused by oxaliplatin: a meta-analysis","volume":"4","author":"Ao","year":"2012","journal-title":"Exp. Ther. Med."},{"issue":"6","key":"10.1016\/j.neuroscience.2026.09.016_b0025","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.4103\/jcrt.JCRT_1123_19","volume":"17","author":"Aoyama","year":"2021","journal-title":"J. Cancer Res. Ther."},{"key":"10.1016\/j.neuroscience.2026.09.016_b0030","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.taap.2017.03.009","article-title":"Carvedilol prevents functional deficits in peripheral nerve mitochondria of rats with oxaliplatin-evoked painful peripheral neuropathy","volume":"322","author":"Areti","year":"2017","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"2","key":"10.1016\/j.neuroscience.2026.09.016_b0035","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3390\/toxics3020187","article-title":"Updates on oxaliplatin-induced peripheral neurotoxicity (OXAIPN)","volume":"3","author":"Argyriou","year":"2015","journal-title":"Toxics"},{"key":"10.1016\/j.neuroscience.2026.09.016_b0040","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1744-8069-9-53","article-title":"The antioxidant effects of the flavonoids rutin and quercetin inhibit oxaliplatin-induced chronic painful peripheral neuropathy","volume":"9","author":"Azevedo","year":"2013","journal-title":"Mol. Pain"},{"issue":"17","key":"10.1016\/j.neuroscience.2026.09.016_b0045","doi-asserted-by":"crossref","first-page":"10063","DOI":"10.3390\/ijms231710063","article-title":"Sodium-calcium exchanger 2: a pivotal role in oxaliplatin induced peripheral neurotoxicity and axonal damage?","volume":"23","author":"Ballarini","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.neuroscience.2026.09.016_b0050","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1177\/1078155219900788","article-title":"Protective effect of N-acetylcysteine on oxaliplatin-induced neurotoxicity in patients with colorectal and gastric cancers: a randomized, double blind, placebo-controlled, clinical trial","volume":"26","author":"Bondad","year":"2020","journal-title":"J. Oncol. Pharm. Pract."},{"issue":"5","key":"10.1016\/j.neuroscience.2026.09.016_b0055","doi-asserted-by":"crossref","first-page":"775","DOI":"10.4103\/1673-5374.232459","article-title":"Sigma-1 receptor: a new player in neuroprotection against chemotherapy-induced peripheral neuropathy","volume":"13","author":"Bruna","year":"2018","journal-title":"Neural Regen. Res."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.09.016_b0060","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s13311-017-0572-5","article-title":"Efficacy of a novel sigma-1 receptor antagonist for oxaliplatin-induced neuropathy: a randomized, double-blind, placebo-controlled phase iia clinical trial","volume":"15","author":"Bruna","year":"2018","journal-title":"Neurotherapeutics"},{"issue":"3","key":"10.1016\/j.neuroscience.2026.09.016_b0065","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1039\/C7MT00334J","article-title":"Relevance of copper transporter 1 and organic cation transporters 1-3 for oxaliplatin uptake and drug resistance in colorectal cancer cells","volume":"10","author":"Bu\u00df","year":"2018","journal-title":"Metallomics"},{"issue":"8","key":"10.1016\/j.neuroscience.2026.09.016_b0070","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.3390\/ijms22083927","article-title":"PEA-OXA mitigates oxaliplatin-induced painful neuropathy through NF-\u03baB\/Nrf-2 axis","volume":"22","author":"Campolo","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"16","key":"10.1016\/j.neuroscience.2026.09.016_b0075","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1200\/JCO.2002.07.061","article-title":"Neuroprotective effect of reduced glutathione on oxaliplatin-based chemotherapy in advanced colorectal cancer: a randomized, double-blind, placebo-controlled trial","volume":"20","author":"Cascinu","year":"2002","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.neuroscience.2026.09.016_b0080","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1158\/1535-7163.MCT-16-0326","article-title":"Niclosamide inhibits oxaliplatin neurotoxicity while improving colorectal cancer therapeutic response","volume":"16","author":"Cerles","year":"2017","journal-title":"Mol. Cancer Ther."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.09.016_b0085","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40478-019-0657-y","article-title":"Preventive action of benztropine on platinum-induced peripheral neuropathies and tumor growth","volume":"7","author":"Cerles","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.09.016_b0090","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13063-019-3972-5","article-title":"The efficacy and safety of electro-acupuncture for alleviating chemotherapy-induced peripheral neuropathy in patients with coloreactal cancer: study protocol for a single-blinded, randomized sham-controlled trial","volume":"21","author":"Chan","year":"2020","journal-title":"Trials"},{"key":"10.1016\/j.neuroscience.2026.09.016_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuro.2025.103368","article-title":"Formononetin protects against oxaliplatin-induced peripheral neurotoxicity via Nrf2\/HO-1 antioxidant pathway without impairing anticancer efficacy","volume":"112","author":"Chang","year":"2026","journal-title":"Neurotoxicology"},{"issue":"1","key":"10.1016\/j.neuroscience.2026.09.016_b0100","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13020-024-00929-7","article-title":"Danggui Sini decoction alleviates oxaliplatin-induced peripheral neuropathy by regulating gut microbiota and potentially relieving neuroinflammation related metabolic disorder","volume":"19","author":"Chen","year":"2024","journal-title":"Chin. Med."},{"issue":"10","key":"10.1016\/j.neuroscience.2026.09.016_b0105","doi-asserted-by":"crossref","first-page":"4672","DOI":"10.7150\/thno.54793","article-title":"Targeting lysosomal cysteine protease cathepsin S reveals immunomodulatory therapeutic strategy for oxaliplatin-induced peripheral neuropathy","volume":"11","author":"Chen","year":"2021","journal-title":"Theranostics"},{"issue":"42","key":"10.1016\/j.neuroscience.2026.09.016_b0110","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000031281","article-title":"Huangqi Guizhi Wuwu decoction in peripheral neurotoxicity treatment using network pharmacology and molecular docking","volume":"101","author":"Chen","year":"2022","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.neuroscience.2026.09.016_b0115","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2024.1345811","article-title":"Current understanding of the molecular mechanisms of chemotherapy-induced peripheral neuropathy","volume":"17","author":"Chen","year":"2024","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neuroscience.2026.09.016_b0120","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1231401","article-title":"Oxaliplatin-induced peripheral neurotoxicity in colorectal cancer patients: mechanisms, pharmacokinetics and strategies","volume":"14","author":"Cheng","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.neuroscience.2026.09.016_b0125","first-page":"3140","article-title":"Tanshinone IIA ameliorates oxaliplatin-induced neurotoxicity via mitochondrial protection and autophagy promotion","volume":"11","author":"Cheng","year":"2019","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.neuroscience.2026.09.016_b0130","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3389\/fphar.2017.00344","article-title":"Herbal medicine AC591 prevents oxaliplatin-induced peripheral neuropathy in animal model and cancer patients","volume":"8","author":"Cheng","year":"2017","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.neuroscience.2026.09.016_b0135","doi-asserted-by":"crossref","first-page":"868","DOI":"10.3390\/ijms21030868","article-title":"GM1 ganglioside is a key factor in maintaining the mammalian neuronal functions avoiding neurodegeneration","volume":"21","author":"Chiricozzi","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.09.016_b0140","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1186\/s12906-016-1396-2","article-title":"Aqueous extract of Lithospermi radix attenuates oxaliplatin-induced neurotoxicity in both in vitro and in vivo models","volume":"16","author":"Cho","year":"2016","journal-title":"BMC Complement. Altern. Med."},{"issue":"5\u20136","key":"10.1016\/j.neuroscience.2026.09.016_b0145","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1515\/znc-2016-0194","article-title":"Effects of Hypericum perforatum extract on oxaliplatin-induced neurotoxicity: in vitro evaluations","volume":"72","author":"Cinci","year":"2017","journal-title":"Z. Naturforsch., C: J. Biosci."},{"issue":"10","key":"10.1016\/j.neuroscience.2026.09.016_b0150","doi-asserted-by":"crossref","first-page":"680","DOI":"10.3390\/metabo15100680","article-title":"A pilot study: comparative effects of green tea extract and duloxetine on oxaliplatin-induced allodynia in a murine model","volume":"15","author":"Daniel","year":"2025","journal-title":"Metabolites"},{"issue":"10","key":"10.1016\/j.neuroscience.2026.09.016_b0155","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1634\/theoncologist.2017-0235","article-title":"Pregabalin for the prevention of oxaliplatin-induced painful neuropathy: a randomized, double-blind trial","volume":"22","author":"de Andrade","year":"2017","journal-title":"Oncologist"},{"issue":"6","key":"10.1016\/j.neuroscience.2026.09.016_b0160","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s12640-025-00775-x","article-title":"Neuroinflammatory mechanisms and therapeutic targets in oxaliplatin-induced peripheral neuropathy: a comprehensive review","volume":"43","author":"Dehghani","year":"2025","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.neuroscience.2026.09.016_b0165","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/7916031","article-title":"Lifestyle-related factors in the self-management of chemotherapy-induced peripheral neuropathy in colorectal cancer: a systematic review","volume":"2017","author":"Derksen","year":"2017","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.neuroscience.2026.09.016_b0170","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.neuropharm.2015.05.037","article-title":"Oxaliplatin evokes P2X7-dependent glutamate release in the cerebral cortex: a pain mechanism mediated by Pannexin 1","volume":"97","author":"Di Cesare Mannelli","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2026.09.016_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105716","article-title":"Neuronal alarmin IL-1\u03b1 evokes astrocyte-mediated protective signals: effectiveness in chemotherapy-induced neuropathic pain","volume":"168","author":"Di Cesare Mannelli","year":"2022","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuroscience.2026.09.016_b0180","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/396908","article-title":"\u03b17 nicotinic receptor promotes the neuroprotective functions of astrocytes against oxaliplatin neurotoxicity","volume":"2015","author":"Di Cesare Mannelli","year":"2015","journal-title":"Neural Plast."},{"issue":"4","key":"10.1016\/j.neuroscience.2026.09.016_b0185","doi-asserted-by":"crossref","first-page":"663","DOI":"10.31083\/j.jin.2020.04.1154","article-title":"Danggui Sini decoction protects against oxaliplatin-induced peripheral neuropathy in rats","volume":"19","author":"Ding","year":"2020","journal-title":"J. Integr. Neurosci."},{"key":"10.1016\/j.neuroscience.2026.09.016_b0190","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.maturitas.2017.05.010","article-title":"Resveratrol alleviates oxidative damage in enteric neurons and associated gastrointestinal dysfunction caused by chemotherapeutic agent oxaliplatin","volume":"105","author":"Donald","year":"2017","journal-title":"Maturitas"},{"issue":"3","key":"10.1016\/j.neuroscience.2026.09.016_b0195","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3892\/etm.2022.11523","article-title":"Resveratrol ameliorates oxaliplatin-induced neuropathic pain via anti-inflammatory effects in rats","volume":"24","author":"Dong","year":"2022","journal-title":"Exp. Ther. Med."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.09.016_b0200","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/annonc\/mdr045","article-title":"Efficacy of venlafaxine for the prevention and relief of oxaliplatin-induced acute neurotoxicity: results of EFFOX, a randomized, double-blind, placebo-controlled phase III trial","volume":"23","author":"Durand","year":"2012","journal-title":"Ann. Oncol."},{"issue":"24","key":"10.1016\/j.neuroscience.2026.09.016_b0205","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.022247","article-title":"Carfilzomib treatment causes molecular and functional alterations of human induced pluripotent stem cell-derived cardiomyocytes","volume":"10","author":"Forghani","year":"2021","journal-title":"J. Am. Heart Assoc."},{"issue":"4","key":"10.1016\/j.neuroscience.2026.09.016_b0210","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1007\/s00280-010-1476-9","article-title":"Pyridoxine to protect from oxaliplatin-induced neurotoxicity without compromising antitumour effect","volume":"67","author":"Garg","year":"2011","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"4","key":"10.1016\/j.neuroscience.2026.09.016_b0215","first-page":"2681","article-title":"Acetyl-L-Carnitine prevents and reverts experimental chronic neurotoxicity induced by oxaliplatin, without altering its antitumor properties","volume":"25","author":"Ghirardi","year":"2005","journal-title":"Anticancer Res"},{"issue":"5","key":"10.1016\/j.neuroscience.2026.09.016_b0220","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.jpainsymman.2017.07.033","article-title":"Oxaliplatin-induced peripheral neuropathy and identification of unique severity groups in colorectal cancer","volume":"54","author":"Griffith","year":"2017","journal-title":"J. Pain Symptom Manage."},{"issue":"5","key":"10.1016\/j.neuroscience.2026.09.016_b0225","first-page":"1223","article-title":"Oral alpha-lipoic acid to prevent chemotherapy-induced peripheral neuropathy: a randomized, double-blind, placebo-controlled trial","volume":"22","author":"Guo","year":"2014","journal-title":"Support Care Cancer"},{"issue":"9","key":"10.1016\/j.neuroscience.2026.09.016_b0230","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1093\/aje\/kwae067","article-title":"The associations of oxaliplatin-induced peripheral neuropathy, sociodemographic characteristics, and clinical characteristics with time to fall in older adults with colorectal cancer","volume":"193","author":"Hines","year":"2024","journal-title":"Am. J. Epidemiol."},{"issue":"5","key":"10.1016\/j.neuroscience.2026.09.016_b0235","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1136\/acupmed-2016-011112","article-title":"Laser acupuncture attenuates oxaliplatin-induced peripheral neuropathy in patients with gastrointestinal cancer: a pilot prospective cohort study","volume":"34","author":"Hsieh","year":"2016","journal-title":"Acupunct. Med."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.09.016_b0240","first-page":"134","article-title":"Quma tongluo prescription in the treatment of chronic oxaliplatin related peripheral neuropathy: a single-center, open, randomized controlled study","volume":"31","author":"Jia","year":"2025","journal-title":"Altern. Ther. Health Med."},{"key":"10.1016\/j.neuroscience.2026.09.016_b0245","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.neuropharm.2015.05.021","article-title":"Oxaliplatin-induced neurotoxicity is mediated through gap junction channels and hemichannels and can be prevented by octanol","volume":"97","author":"Kagiava","year":"2015","journal-title":"Neuropharmacology"},{"issue":"9","key":"10.1016\/j.neuroscience.2026.09.016_b0250","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1007\/s00415-020-09942-w","article-title":"Oxaliplatin-induced peripheral neuropathy: clinical features, mechanisms, prevention and treatment","volume":"268","author":"Kang","year":"2021","journal-title":"J. Neurol."},{"issue":"3","key":"10.1016\/j.neuroscience.2026.09.016_b0255","doi-asserted-by":"crossref","first-page":"608","DOI":"10.3390\/antiox12030608","article-title":"Exacerbated neuropathy in POLAR a and M trials due to redox interaction of pledox-associated Mn2+ and oxaliplatin-associated Pt2","volume":"12","author":"Karlsson","year":"2023","journal-title":"Antioxidants (Basel)"},{"issue":"5","key":"10.1016\/j.neuroscience.2026.09.016_b0260","article-title":"Effect of melatonin on oxaliplatin induced neuropathy in patients receiving folfox chemotherapy regimens for stage ii-iv colorectal cancer: a randomized, placebo controlled","volume":"8","author":"Kheshti","year":"2025","journal-title":"Double Blind Trial. Health Sci Rep"},{"issue":"6","key":"10.1016\/j.neuroscience.2026.09.016_b0265","doi-asserted-by":"crossref","first-page":"726","DOI":"10.3390\/ph15060726","article-title":"[6]-Shogaol attenuates oxaliplatin-induced allodynia through serotonergic receptors and GABA in the spinal cord in mice","volume":"15","author":"Kim","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.neuroscience.2026.09.016_b0270","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.lfs.2015.03.013","article-title":"Protective effects of phosphatidylcholine on oxaliplatin-induced neuropathy in rats","volume":"130","author":"Kim","year":"2015","journal-title":"Life Sci."},{"key":"10.1016\/j.neuroscience.2026.09.016_b0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118272","article-title":"Lansoprazole identified as a prophylactic agent for oxaliplatin-induced peripheral neuropathy using integrated in silico, in vitro, and in vivo analyses","volume":"189","author":"Kobayashi","year":"2025","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.09.016_b0280","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3390\/ijms23010098","article-title":"The class I HDAC inhibitor, MS-275, prevents oxaliplatin-induced chronic neuropathy and potentiates its antiproliferative activity in mice","volume":"23","author":"Lamoine","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"23","key":"10.1016\/j.neuroscience.2026.09.016_b0285","doi-asserted-by":"crossref","first-page":"8138","DOI":"10.3390\/molecules27238138","article-title":"Syringaresinol alleviates oxaliplatin-induced neuropathic pain symptoms by inhibiting the inflammatory responses of spinal microglia","volume":"27","author":"Lee","year":"2022","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.neuroscience.2026.09.016_b0290","first-page":"54","article-title":"Prevention of oxaliplatin-induced peripheral sensory neuropathy by carbamazepine in patients with advanced colorectal cancer","volume":"2","author":"Lersch","year":"2002","journal-title":"Clin. Colorectal Cancer"},{"issue":"7","key":"10.1016\/j.neuroscience.2026.09.016_b0295","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.3390\/toxins7072422","article-title":"Analgesic effects of bee venom derived phospholipase A(2) in a mouse model of oxaliplatin-induced neuropathic pain","volume":"7","author":"Li","year":"2015","journal-title":"Toxins (Basel)"},{"issue":"12","key":"10.1016\/j.neuroscience.2026.09.016_b0300","doi-asserted-by":"crossref","first-page":"5013","DOI":"10.18632\/aging.203794","article-title":"Huangqi Guizhi Wuwu Decoction can prevent and treat oxaliplatin-induced neuropathic pain by TNF\u03b1\/IL-1\u03b2\/IL-6\/MAPK\/NF-kB pathway","volume":"14","author":"Li","year":"2022","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"10.1016\/j.neuroscience.2026.09.016_b0305","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/BF02857424","article-title":"Clinical study of Jiawei Huangqi Guizhi Wuwu Decoction in preventing and treating peripheral neuro-sensory toxicity caused by oxaliplatin","volume":"12","author":"Li","year":"2006","journal-title":"Chin. J. Integr. Med."},{"key":"10.1016\/j.neuroscience.2026.09.016_b0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2024.149895","article-title":"Non-cytotoxic nanomolar concentration of arctigenin protects neuronal cells from chemotherapy-induced ferroptosis by regulating SLC7A11-cystine-cysteine axis","volume":"710","author":"Li","year":"2024","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuroscience.2026.09.016_b0315","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.2147\/IJN.S233747","article-title":"Topical delivery of four neuroprotective ingredients by ethosome-gel: synergistic combination for treatment of oxaliplatin-induced peripheral neuropathy","volume":"15","author":"Lin","year":"2020","journal-title":"Int. J. Nanomed."},{"issue":"12","key":"10.1016\/j.neuroscience.2026.09.016_b0320","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1158\/2326-6066.CIR-22-0197","article-title":"NET-triggered NLRP3 activation and IL18 release drive oxaliplatin-induced peripheral neuropathy","volume":"10","author":"Lin","year":"2022","journal-title":"Cancer Immunol. Res."},{"issue":"5","key":"10.1016\/j.neuroscience.2026.09.016_b0325","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/mus.27812","article-title":"Loss of astrocytic A1 adenosine receptor is involved in a chemotherapeutic agent-induced rodent model of neuropathic pain","volume":"67","author":"Liu","year":"2023","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neuroscience.2026.09.016_b0330","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/541217","article-title":"Clinical study on the prevention of oxaliplatin-induced neurotoxicity with guilongtongluofang: results of a randomized, double-blind, placebo-controlled trial","volume":"2013","author":"Liu","year":"2013","journal-title":"Evid. Based Complement. Alternat. Med."},{"issue":"6","key":"10.1016\/j.neuroscience.2026.09.016_b0335","first-page":"1234","article-title":"Traditional Chinese medicine syndrome analysis on oxaliplatin-induced peripheral neuropathy and clinical efficacy of Bushen Yiqi formula: a prospective randomized controlled study","volume":"43","author":"Longci","year":"2023","journal-title":"J. Tradit. Chin. Med."},{"issue":"10","key":"10.1016\/j.neuroscience.2026.09.016_b0340","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1200\/JCO.2013.52.0536","article-title":"Phase III randomized, placebo-controlled, double-blind study of intravenous calcium and magnesium to prevent oxaliplatin-induced sensory neurotoxicity (N08CB\/Alliance)","volume":"32","author":"Loprinzi","year":"2014","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.09.016_b0345","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0170814","article-title":"Characterisation of immune and neuroinflammatory changes associated with chemotherapy-induced peripheral neuropathy","volume":"12","author":"Makker","year":"2017","journal-title":"PLoS One"},{"issue":"32","key":"10.1016\/j.neuroscience.2026.09.016_b0350","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.2174\/0929867322666151001121302","article-title":"Calcium-related neurotoxicity of oxaliplatin: understanding the mechanisms to drive therapy","volume":"22","author":"Marmiroli","year":"2015","journal-title":"Curr. Med. Chem."},{"issue":"3","key":"10.1016\/j.neuroscience.2026.09.016_b0355","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1007\/s13311-020-00873-y","article-title":"The use of the selective imidazoline i1 receptor agonist carbophenyline as a strategy for neuropathic pain relief: preclinical evaluation in a mouse model of oxaliplatin-induced neurotoxicity","volume":"17","author":"Micheli","year":"2020","journal-title":"Neurotherapeutics"},{"issue":"1","key":"10.1016\/j.neuroscience.2026.09.016_b0360","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3390\/nu17010121","article-title":"The unripe carob extract (Ceratonia siliqua L.) as a potential therapeutic strategy to fight oxaliplatin-induced neuropathy","volume":"17","author":"Micheli","year":"2024","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.neuroscience.2026.09.016_b0365","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1186\/s13046-021-02127-x","article-title":"VEGF-A\/VEGFR-1 signalling and chemotherapy-induced neuropathic pain: therapeutic potential of a novel anti-VEGFR-1 monoclonal antibody","volume":"40","author":"Micheli","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.09.016_b0370","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1254\/jphs.13244FP","article-title":"Goshajinkigan, a traditional Japanese medicine, prevents oxaliplatin-induced acute peripheral neuropathy by suppressing functional alteration of TRP channels in rat","volume":"125","author":"Mizuno","year":"2014","journal-title":"J. Pharmacol. Sci."},{"issue":"2","key":"10.1016\/j.neuroscience.2026.09.016_b0375","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/CAD.0000000000000177","article-title":"Gc-protein-derived macrophage activating factor counteracts the neuronal damage induced by oxaliplatin","volume":"26","author":"Morucci","year":"2015","journal-title":"Anticancer Drugs"},{"issue":"11","key":"10.1016\/j.neuroscience.2026.09.016_b0380","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1158\/2767-9764.CRC-22-0172","article-title":"Targeting OCT2 with duloxetine to prevent oxaliplatin-induced peripheral neurotoxicity","volume":"2","author":"Nepal","year":"2022","journal-title":"Cancer Res. Commun."},{"issue":"4","key":"10.1016\/j.neuroscience.2026.09.016_b0385","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s10147-015-0784-9","article-title":"Preventive effect of Goshajinkigan on peripheral neurotoxicity of FOLFOX therapy (GENIUS trial): a placebo-controlled, double-blind, randomized phase III study","volume":"20","author":"Oki","year":"2015","journal-title":"Int. J. Clin. Oncol."},{"key":"10.1016\/j.neuroscience.2026.09.016_b0390","article-title":"Escape from cisplatin-induced senescence of hypoxic lung cancer cells can be overcome by hydroxychloroquine","volume":"11","author":"Olszewska","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.neuroscience.2026.09.016_b0395","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.expneurol.2016.04.022","article-title":"The \u03b19\u03b110 nicotinic receptor antagonist \u03b1-conotoxin RgIA prevents neuropathic pain induced by oxaliplatin treatment","volume":"282","author":"Pacini","year":"2016","journal-title":"Exp. Neurol."},{"issue":"11","key":"10.1016\/j.neuroscience.2026.09.016_b0400","doi-asserted-by":"crossref","DOI":"10.1590\/1414-431x202010263","article-title":"Amifostine protects from the peripheral sensory neuropathy induced by oxaliplatin in mice","volume":"53","author":"Pereira","year":"2020","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.neuroscience.2026.09.016_b0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2019.134378","article-title":"Metformin reduces c-Fos and ATF3 expression in the dorsal root ganglia and protects against oxaliplatin-induced peripheral sensory neuropathy in mice","volume":"709","author":"Pereira","year":"2019","journal-title":"Neurosci. Lett."},{"issue":"4","key":"10.1016\/j.neuroscience.2026.09.016_b0410","doi-asserted-by":"crossref","DOI":"10.1111\/jns.70078","article-title":"Molecular characterization of oxaliplatin-induced peripheral neurotoxicity: the complex spectrum of painful manifestations","volume":"30","author":"Pozzi","year":"2025","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.neuroscience.2026.09.016_b0415","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1642552","article-title":"Anti-oxidative stress therapies prevent severe chemotherapy-induced peripheral neuropathy in colorectal cancer patients treated with oxaliplatin: a systematic review and meta-analysis","volume":"15","author":"Salama","year":"2025","journal-title":"Front. Oncol."},{"issue":"9","key":"10.1016\/j.neuroscience.2026.09.016_b0420","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s00210-014-0994-0","article-title":"Effects of the compounds resveratrol, rutin, quercetin, and quercetin nanoemulsion on oxaliplatin-induced hepatotoxicity and neurotoxicity in mice","volume":"387","author":"Schwingel","year":"2014","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.neuroscience.2026.09.016_b0425","article-title":"Effectiveness and cost-utility analysis of different doses of irinotecan plus bevacizumab in patients with metastatic colorectal cancer: a long-term and prospective cohort study","volume":"12","author":"Shi","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.neuroscience.2026.09.016_b0430","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.3389\/fphar.2019.01522","article-title":"Inhibitory effects of columbianadin on nociceptive behaviors in a neuropathic pain model, and on voltage-gated calcium currents in dorsal root ganglion neurons in mice","volume":"10","author":"Su","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"17","key":"10.1016\/j.neuroscience.2026.09.016_b0435","doi-asserted-by":"crossref","first-page":"9983","DOI":"10.3390\/ijms23179983","article-title":"Pretreatment with zonisamide mitigates oxaliplatin-induced toxicity in rat DRG neurons and DRG neuron-schwann cell co-cultures","volume":"23","author":"Takaku","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.neuroscience.2026.09.016_b0440","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00280-020-04143-8","article-title":"Ibudilast for prevention of oxaliplatin-induced acute neurotoxicity: a pilot study assessing preliminary efficacy, tolerability and pharmacokinetic interactions in patients with metastatic gastrointestinal cancer","volume":"86","author":"Teng","year":"2020","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"2","key":"10.1016\/j.neuroscience.2026.09.016_b0445","first-page":"1103","article-title":"Neu-horizons: neuroprotection and therapeutic use of riluzole for the prevention of oxaliplatin-induced neuropathy-a randomised controlled trial","volume":"29","author":"Trinh","year":"2021","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.neuroscience.2026.09.016_b0450","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2025.107309","article-title":"Esomeprazole prevents oxaliplatin-induced peripheral neuropathy through inhibiting organic cation transporter 2 in mice","volume":"214","author":"Ueno","year":"2025","journal-title":"Eur. J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.neuroscience.2026.09.016_b0455","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1177\/10998004231209444","article-title":"Effectiveness of duloxetine on oxaliplatin-induced allodynia and hyperalgesia in rats","volume":"26","author":"Wagner","year":"2024","journal-title":"Biol. Res. Nurs."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.09.016_b0460","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/cam4.2693","article-title":"Phase III randomized, placebo-controlled, double-blind study of monosialotetrahexosylganglioside for the prevention of oxaliplatin-induced peripheral neurotoxicity in stage II\/III colorectal cancer","volume":"9","author":"Wang","year":"2020","journal-title":"Cancer Med."},{"issue":"9","key":"10.1016\/j.neuroscience.2026.09.016_b0465","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s11655-022-2896-1","article-title":"Protective mechanism of electroacupuncture on peripheral neurotoxicity induced by oxaliplatin in rats","volume":"28","author":"Wang","year":"2022","journal-title":"Chin. J. Integr. Med."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.09.016_b0470","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1080\/15376516.2022.2069531","article-title":"Utilizing network pharmacological analysis to investigate the key targets and mechanisms of kaempferol against oxaliplatin-induced neurotoxicity","volume":"33","author":"Wang","year":"2023","journal-title":"Toxicol. Mech. Methods"},{"issue":"3","key":"10.1016\/j.neuroscience.2026.09.016_b0475","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1634\/theoncologist.12-3-312","article-title":"Oral glutamine is effective for preventing oxaliplatin-induced neuropathy in colorectal cancer patients","volume":"12","author":"Wang","year":"2007","journal-title":"Oncologist"},{"issue":"7","key":"10.1016\/j.neuroscience.2026.09.016_b0480","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0180953","article-title":"Melatonin pre-treatment mitigates SHSY-5Y cells against oxaliplatin induced mitochondrial stress and apoptotic cell death","volume":"12","author":"Waseem","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.neuroscience.2026.09.016_b0485","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/jns.12432","article-title":"Platinum accumulation in oxaliplatin-induced peripheral neuropathy","volume":"26","author":"Wei","year":"2021","journal-title":"J. Peripher. Nerv. Syst."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.09.016_b0490","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/annonc\/mds211","article-title":"Ca\/Mg infusions for the prevention of oxaliplatin-related neurotoxicity in patients with colorectal cancer: a meta-analysis","volume":"24","author":"Wen","year":"2013","journal-title":"Ann. Oncol."},{"issue":"4","key":"10.1016\/j.neuroscience.2026.09.016_b0495","first-page":"993","article-title":"Curcumin exerts protective effects against hypoxia\u2011reoxygenation injury via the enhancement of apurinic\/apyrimidinic endonuclease 1 in SH\u2011SY5Y cells: involvement of the PI3K\/AKT pathway","volume":"45","author":"Wu","year":"2020","journal-title":"Int. J. Mol. Med."},{"issue":"12","key":"10.1016\/j.neuroscience.2026.09.016_b0500","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/j.ejca.2012.03.018","article-title":"Infusion of calcium and magnesium for oxaliplatin-induced sensory neurotoxicity in colorectal cancer: a systematic review and meta-analysis","volume":"48","author":"Wu","year":"2012","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.neuroscience.2026.09.016_b0505","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2147\/DDDT.S262818","article-title":"Network pharmacology and experimental evidence identify the mechanism of astragaloside IV in oxaliplatin neurotoxicity","volume":"15","author":"Xu","year":"2021","journal-title":"Drug Des. Devel. Ther."},{"issue":"6","key":"10.1016\/j.neuroscience.2026.09.016_b0510","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/1751-2980.12050","article-title":"Safety and efficacy of calcium and magnesium infusions in the chemoprevention of oxaliplatin-induced sensory neuropathy in gastrointestinal cancers","volume":"14","author":"Xu","year":"2013","journal-title":"J. Dig. Dis."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.09.016_b0515","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.23229","article-title":"Emodin suppresses oxaliplatin-induced neuropathic pain by inhibiting COX2\/NF-\u03baB mediated spinal inflammation","volume":"37","author":"Yang","year":"2023","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.neuroscience.2026.09.016_b0520","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.157039","article-title":"Huangqi guizhi wuwu decoction alleviate oxaliplatin-induced peripheral neuropathy by adjusting the myelin regeneration","volume":"145","author":"Yang","year":"2025","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.neuroscience.2026.09.016_b0525","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1186\/s13046-021-02141-z","article-title":"Targeting strategies for oxaliplatin-induced peripheral neuropathy: clinical syndrome, molecular basis, and drug development","volume":"40","author":"Yang","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.09.016_b0530","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1186\/s12906-019-2761-8","article-title":"Ameliorative effects of aqueous extract of Forsythiae suspensa fruits on oxaliplatin-induced neurotoxicity in vitro and in vivo","volume":"19","author":"Yi","year":"2019","journal-title":"BMC Complement. Altern. Med."},{"issue":"6","key":"10.1016\/j.neuroscience.2026.09.016_b0535","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.3390\/molecules24061177","article-title":"Neuroprotective effects of an aqueous extract of forsythia viridissima and its major constituents on oxaliplatin-induced peripheral neuropathy","volume":"24","author":"Yi","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.neuroscience.2026.09.016_b0540","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2021.152853","article-title":"L-tetrahydropalmatine reduces oxaliplatin accumulation in the dorsal root ganglion and mitochondria through selectively inhibiting the transporter-mediated uptake thereby attenuates peripheral neurotoxicity","volume":"459","author":"Yi","year":"2021","journal-title":"Toxicology"},{"key":"10.1016\/j.neuroscience.2026.09.016_b0545","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/139740","article-title":"Efficacy of goshajinkigan for oxaliplatin-induced peripheral neuropathy in colorectal cancer patients","volume":"2013","author":"Yoshida","year":"2013","journal-title":"J. Oncol."},{"issue":"7","key":"10.1016\/j.neuroscience.2026.09.016_b0550","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0102758","article-title":"Oxaliplatin neurotoxicity involves peroxisome alterations. PPAR\u03b3 agonism as preventive pharmacological approach","volume":"9","author":"Zanardelli","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.neuroscience.2026.09.016_b0555","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1002\/cbin.12153","article-title":"Curcumin relieves oxaliplatin-induced neuropathic pain via reducing inflammation and activating antioxidant response","volume":"48","author":"Zhang","year":"2024","journal-title":"Cell Biol. Int."},{"issue":"12","key":"10.1016\/j.neuroscience.2026.09.016_b0560","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1007\/s00384-012-1509-4","article-title":"Neuroprotective effect of neurotropin on chronic oxaliplatin-induced neurotoxicity in stage II and stage III colorectal cancer patients: results from a prospective, randomised, single-centre, pilot clinical trial","volume":"27","author":"Zhang","year":"2012","journal-title":"Int. J. Colorectal Dis."},{"issue":"50","key":"10.1016\/j.neuroscience.2026.09.016_b0565","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000023564","article-title":"Prevention of oxaliplatin-related neurotoxicity by \u03c9-3 PUFAs: a double-blind randomized study of patients receiving oxaliplatin combined with capecitabine for colon cancer","volume":"99","author":"Zhang","year":"2020","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.neuroscience.2026.09.016_b0570","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13020-023-00826-5","article-title":"Huangqi Guizhi Wuwu decoction alleviates oxaliplatin-induced peripheral neuropathy via the gut-peripheral nerve axis","volume":"18","author":"Zhang","year":"2023","journal-title":"Chin. Med."},{"key":"10.1016\/j.neuroscience.2026.09.016_b0575","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.expneurol.2018.09.014","article-title":"Tat-HA-NR2B9c attenuate oxaliplatin-induced neuropathic pain","volume":"311","author":"Zhou","year":"2019","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuroscience.2026.09.016_b0580","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.freeradbiomed.2018.04.570","article-title":"Neurotoxicity of cytarabine (Ara-C) in dorsal root ganglion neurons originates from impediment of mtDNA synthesis and compromise of mitochondrial function","volume":"121","author":"Zhuo","year":"2018","journal-title":"Free Radic. Biol. Med."},{"issue":"3","key":"10.1016\/j.neuroscience.2026.09.016_b0585","first-page":"1071","article-title":"MC11C4: a pilot randomized, placebo-controlled, double-blind study of venlafaxine to prevent oxaliplatin-induced neuropathy","volume":"24","author":"Zimmerman","year":"2016","journal-title":"Support Care Cancer"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452226006275?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452226006275?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T08:26:49Z","timestamp":1791880009000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452226006275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":117,"alternative-id":["S0306452226006275"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2026.09.016","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting oxaliplatin-induced peripheral neuropathy: neurobiological mechanisms, therapeutic evidence, and translational perspectives","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2026.09.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Brain Research Organization (IBRO). Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}